According to Cormedix's latest financial reports the company's current EPS (TTM) is -$0.86. In 2022 the company made an earnings per share (EPS) of -$0.74 a decrease over its 2021 EPS that were of -$0.74.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.86 | 16.22% |
2022 | -$0.74 | -0% |
2021 | -$0.74 | -2.63% |
2020 | -$0.76 | -58.01% |
2019 | -$1.81 | 10.37% |
2018 | -$1.64 | -46.23% |
2017 | -$3.05 | -3.17% |
2016 | -$3.15 | 5% |
2015 | -$3.00 | -43.93% |
2014 | -$5.35 | 55.07% |
2013 | -$3.45 | 130% |
2012 | -$1.50 | -48.28% |
2011 | -$2.90 | -90.89% |
2010 | -$31.85 | -32.88% |
2009 | -$47.45 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Becton Dickinson BDX | $5.55 | -745.35% | ๐บ๐ธ USA |
Utah Medical Products UTMD | $4.65 | -641.03% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | -$12.08 | 1,304.65% | ๐บ๐ธ USA |